Substance P(SP) and Calcitonin-gene related peptide(CGRP), the most well known pain-related neuropeptides, are known to be increased in experimental arthritis. However, in experimental arthritic rat, mechanisms underling analgesic action of COX-2 inhi...
Substance P(SP) and Calcitonin-gene related peptide(CGRP), the most well known pain-related neuropeptides, are known to be increased in experimental arthritis. However, in experimental arthritic rat, mechanisms underling analgesic action of COX-2 inhibitor and the relationship between changes of SP and CGRP expression in spinal cord level and the changes of the pain remains yet unclear.
The present study was to investigate the effects of cyclooxygenase-2 (COX-2) inhibitor NS-398 on the changes of SP and CGRP expression in the spinal cord and pain-related behavior in experimental arthritic rat model.
The arthritis was induced by carrageenan (2% in saline, 50㎕)injection into the knee joint cavity. Pain-related behavior (i.e., decrease in weight load in the affected leg) and the expression of spinal SP and CGRP by immunohistochemical analysis were measured.
Injection of carrageenan into the knee joint cavity resulted in a significant decrease of weight load and increase of SP and CGRP expression in the dorsal horn of the L4 and L5 level. However, pre-treatment of NS-398 (5mg/kg, 1 ㎖) prevented the reduction of weight load of carrageenan-injected leg and post-treatment of NS-398 partially reversed the reduction of weight load induced by carrageenan injection. Spinal SP and CGRP immunoreactivitys in the spinal cord were reduced following pre- and post-treatment of NS-398, except for SP expression in L5. These results suggest that the analgesic effect of COX-2 inhibitor may arise via modulating the expression of spinal SP and CGRP.